Vaccination is a fundamental component of preventive medicine and public health. The use of vaccines to prevent infectious diseases has resulted in dramatic decreases in disease, disability, and death in the United States and around the world. The current political, economic, and social environment presents both opportunities for and challenges to strengthening the U.S. system for developing, manufacturing, regulating, distributing, funding, and administering safe and effective vaccines for all people. Priorities for the National Vaccine Plan examines the extraordinarily complex vaccine enterprise, from research and development of new vaccines to financing and reimbursement of immunization services.
Priorities for the National Vaccine Plan examines the extraordinarily complex vaccine enterprise, from research and development of new vaccines to financing and reimbursement of immunization services. The book makes recommendations about priority actions in the update to the National Vaccine Plan that are intended to achieve the objectives of disease prevention and enhancement of vaccine safety. It is centered on the plan's five goals in the areas of vaccine development, safety, communication, supply and use, and global health.
Table of Contents
|1 Development of New and Improved Vaccines||31-50|
|2 The Safety of Vaccines and Vaccination Practices||51-78|
|3 Informed Vaccine Decision Making||79-96|
|4 Vaccine Supply and Use||97-120|
|5 Vaccines and Global Health||121-138|
|Appendix A: Draft Strategic National Vaccine Plan||153-238|
|Appendix B: Letter to the Committee from the National Vaccine Advisory Committee||239-242|
|Appendix C: 1986 National Childhood Vaccine Injury Act (Public Law 99-660)||243-272|
|Appendix D: Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office||273-312|
|Appendix E: History of Public Engagement at the National Vaccine Program Office||313-316|
|Appendix F: Agendas of Stakeholder Meetings Held by the Committee on Review of Priorities in the National Vaccine Plan (July 2008-June 2009)||317-344|
|Appendix G: Acronyms||345-348|
|Appendix H: Committee Biographies||349-356|
The National Academies Press (NAP) has partnered with Copyright Clearance Center's Rightslink service to offer you a variety of options for reusing NAP content. Through Rightslink, you may request permission to reprint NAP content in another publication, course pack, secure website, or other media. Rightslink allows you to instantly obtain permission, pay related fees, and print a license directly from the NAP website. The complete terms and conditions of your reuse license can be found in the license agreement that will be made available to you during the online order process. To request permission through Rightslink you are required to create an account by filling out a simple online form. The following list describes license reuses offered by the National Academies Press (NAP) through Rightslink:
Click here to obtain permission for the above reuses. If you have questions or comments concerning the Rightslink service, please contact:
Rightslink Customer Care
Tel (toll free): 877/622-5543
To request permission to distribute a PDF, please contact our Customer Service Department at 800-624-6242 for pricing.
To request permission to translate a book published by the National Academies Press or its imprint, the Joseph Henry Press, please click here to view more information.